Hirsutism relatively is a common medical problem and an important influence on about 5-10% of women of reproductive age. Fifty five female shares in the study, seventeen of them did not continue the study, therefore we evaluated 38 females, aged 18-52 years old. In our study we compared pre-treatment and post-treatment for the color of the hairs and the hair removal frequency and the pain during hair removal for four groups which are good response group and moderate response group and mild response group and no response group, by subjective evaluation of all the patients noted a diminished rate of hair growth (fewer times needed for shaving) and a decrement in the density of hairs on the chin area and change in color of the hair but there was no significant difference between groups regarding hair color and there were highly significant difference in hair removal frequency before and after treatment (P<0.001) when we used finasteride cream 1% for 3 months. Six months of topically applied finasteride (0.5%) does not effect on number and thickness of facial hirsutism significantly.
Introduction
The term hirsutism defines as presence of coarser, thicker and terminal hair in women in a male like pattern and locations [1] . Hirsutism relatively is a common medical problem and an important influence on about 5-10% of women of reproductive age [2, 3] . The prevalence of hirsutism is dependent on the ethnic and racial origin of the population under study, an incidence of hirsutism of 8% was found in the US [4] .
The androgen responsible for the change in voice and the increase in muscle mass in women is testosterone, and that responsible for hirsutism is 5-α-dihydrotestosterone (5α-DHT) [5] . The testosterone is the key circulating androgen which is produced by the ovaries and adrenals either as testosterone or as prohormones (mainly androstenedione and dehydroepiandrosteron sulfate) which are metabolized into testosterone in the peripheral tissues such as fat [6] . androgens [3] . "Idiopathic hirsutism"
(IH), also called simple or peripheral hirsutism, while IH is often referred to as "familial hirsutism," this represents a misnomer. In fact, it is now well established that other forms of hyperandrogenism, e.g., PCOS and NCAH, also demonstrate a strong familial predisposition [7] .
Material and Method
The present study was carried out in 
Results

Statistical analysis
Fifty five females shares in the study. Hormonal assessment before and after treatment for all patients. 
Figure 7.
FSH level before and after treatment among good response group, there is no significant difference of FST level after treatment for good response group patients.
Figure 8.
Free testosterone level before and after treatment among good response group. Finasteride is considered to be a potent non-steroidal antiandrogen that acts by inhibiting the type 2-5 α-reductase isoenzyme, blocking the conversion of testosterone to 5-α-DHT, with a significant reduction of serum 5α-DHT levels and no prominent side-effects. TSH level before and after treatment among moderate response group, in moderate response group we have slightly decrease in the TSH levels.
Figure 10.
LH level before and after treatment among moderate response group, in moderate response group we have slightly decrease in the LH levels.
Figure 11.
FSH level before and after treatment among moderate response group, in moderate response group we have slightly increase in the FSH levels.
Figure 12.
Free test level before and after treatment among moderate response group, in moderate response group we have slightly increase in the free testosterone levels. LH level before and after treatment among mild response group, n mild response group we have slightly decrease in the LH levels. Free test level before and after treatment among mild response group, in mild response group we have slightly increase in the free testosterone levels. Table 5 .
Hormonal assessment before and after treatment among no response group. Free test level before and after treatment among no response group.
Table 6.
Hair color (for all Patients). Table 7 .
Hair color for each group Table 8 . Hair removal frequency of the patients. Table 9 .
Hair removal-good response. American Journal of BioMedicine AJBM 2015; 3(9):552 -566 doi:10.18081/2333-5106/015-09/552-566 Table 11 . Hair removal-mild response.
Table 12.
Hair removal-no response. Table 13 . Pain severity before and after treatment. Follow up with F-Gallawy score, there is a significant difference in the score with time so the score is higher in the first 2 weeks while it is lower in the sixth 2 weeks, (Friedman test). Table 15 . F-Gallawy good response, in good response group they had significant differences between pre-treatment and first month and between pretreatment and third month. Table 16 . F-G moderate response, in good response group they had significant differences between pretreatment and third month. Table 17 . F-G no response, in non-response group they had no significant differences between pre-treatment and all months. Table 18 . F-G mild response, in mild response group they had also no significant differences between pretreatment and all months. Table 19 . Visual analogue score, There was highly significant difference in visual analogue score in different months which is higher pre-treatment and lowest in third month (Friedman test). Table 20 . Visual analogue-good response, There was significant difference between pre-treatment with all other periods and significant difference between first month and second and third month but no significant difference between second and third month. Table 21 . Visual analogue-moderate response, The significant difference is only between pretreatment and other periods while between the first, second, and third months no significant difference. Table 22 . Visual analogue-no response, the significant difference is only between pre-treatment and other periods while between the first, second, and third months no significant difference. Table 23 . Visual analogue-mild response, the significant difference is only between pre-treatment and other periods while between the first, second, and third months no significant difference.
Discussion
Many of antiandrogen drugs such as spironolactone, finasteride, cyproterone acetate, flutamide have been used in the treatment of hirsutism as a single drug or in combination [8, 9] . Long period of treatment is always required to improve hirsutism and to prevent or to delay its relapse, increased 5α-reductase activity has been shown on the skin of the women with idiopathic hirsutism [10] .
The use of finasteride for treatment of hirsutism is logical because of its specific effect on 5α-reductase, the enzyme responsible for sensitizing the hair to testosterone. In other studies, finasteride administered orally has been successfully used in the treatment of hirsutism [11, 12] . Its contraindications in women due to its effect on the developing male fetus. It inhibits development of normal male genitalia [11] . In our study we compared pre- 
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